Evidence
[1] Original publication
Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Introduced the discriminant function combining prothrombin time and bilirubin; patients with a high value had substantial short-term mortality and appeared to benefit most from corticosteroids.
Gastroenterology, 1978
[2] Validation
Carithers RL Jr, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. Used the modified discriminant function 4.6·(PT − control) + bilirubin with a threshold of 32 to define severe disease; corticosteroids reduced 28-day mortality in that group.
Annals of Internal Medicine, 1989
[3] Guideline
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Uses the discriminant function and MELD to assess the severity of alcohol-associated hepatitis.
Hepatology, 2020
Last reviewed: 2026-10
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
More in Gastroenterology & Hepatology
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.